Welcome to the latest issue of the Canadian Securities Exchange Magazine, your source for in-depth stories of entrepreneurs from a wealth of different industries.
Psychedelics has emerged as a rapidly-evolving industry in the last few years. In this issue of Canadian Securities Exchange Magazine, we’re thrilled to share stories of visionary entrepreneurs in this sector.
We shine a spotlight on five publicly-listed psychedelics companies on the CSE who are looking back to older medicines in order to move forward, and developing innovative treatments designed to achieve better health outcomes for people experiencing mental health conditions, chronic pain, addiction, and more.
The CSE-listed companies featured in this issue include:
- Revitalist Lifestyle and Wellness (CSE:CALM)
- Entheon Biomedical (CSE:ENBI)
- Bright Minds Biosciences (CSE:DRUG)
- Wesana Health Holdings (CSE:WESA)
- Mindset Pharma (CSE:MSET)
Check out the Psychedelics Issue of Canadian Securities Exchange Magazine here: